445 results on '"Carlsten, Hans"'
Search Results
2. Role of estrogen signaling in fibroblastic reticular cells for innate and adaptive immune responses in antigen‐induced arthritis
3. Local Immune Activation and Age Impact on Humoral Immunity in Mice, with a Focus on IgG Sialylation.
4. Bazedoxifene does not share estrogens effects on IgG sialylation
5. Effects of a tissue-selective estrogen complex on B lymphopoiesis and B cell function
6. Ovarian hormones in innate inflammation
7. A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin
8. IL-17-producing γδT cells are regulated by estrogen during development of experimental arthritis
9. Impact of estrogen on IgG glycosylation and serum protein glycosylation in a murine model of healthy postmenopause.
10. Selective estrogen receptor modulators in T cell development and T cell dependent inflammation
11. Reduction of Mature B Cells and Immunoglobulins Results in Increased Trabecular Bone
12. Testosterone Protects Against Atherosclerosis in Male Mice by Targeting Thymic Epithelial Cells—Brief Report
13. The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when estrogen receptor α AF-2 is modified
14. Interaction with Estrogen Receptors as Treatment of Arthritis and Osteoporosis
15. A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis
16. Methotrexate inhibits effects of platelet-derived growth factor and interleukin-1β on rheumatoid arthritis fibroblast-like synoviocytes
17. ERα Signaling in a Subset of CXCL12 ‐Abundant Reticular Cells Regulates Trabecular Bone in Mice
18. Sexual dimorphisms in the immune system of catechol-O-methyltransferase knockout mice
19. Estrogen receptor-α expression in neuronal cells affects bone mass
20. sj-pdf-1-lup-10.1177_09612033211067984 ��� Supplemental Material for A tissue-selective estrogen complex as treatment of osteoporosis in experimental lupus
21. Ethanol Prevents Development of Destructive Arthritis
22. A tissue-selective estrogen complex as treatment of osteoporosis in experimental lupus
23. Bazedoxifene and Tissue-Selective Estrogen Complex do not Share Estrogens Effects on IgG Sialylation
24. Rapid Systemic Bone Resorption during the Course of Staphylococcus aureus-Induced Arthritis
25. Selective oestrogen receptor modulators lasofoxifene and bazedoxifene inhibit joint inflammation and osteoporosis in ovariectomised mice with collagen-induced arthritis
26. Suppression of Experimental Arthritis and Associated Bone Loss by a Tissue-Selective Estrogen Complex
27. Androgens Regulate Bone Marrow B Lymphopoiesis in Male Mice by Targeting Osteoblast-Lineage Cells
28. Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis
29. Role of Androgen and Estrogen Receptors for the Action of Dehydroepiandrosterone (DHEA)
30. Intermediate monocytes correlate with CXCR3+ Th17 cells but not with bone characteristics in untreated early rheumatoid arthritis
31. Periarticular Bone Loss in Antigen-Induced Arthritis
32. Androgen Receptors in Epithelial Cells Regulate Thymopoiesis and Recent Thymic Emigrants in Male Mice
33. Immunoglobulin G complexes without sialic acids enhance osteoclastogenesis but do not affect arthritis‐mediated bone loss
34. Interleukin-6-deficient mice develop mature-onset obesity
35. Estrogen receptor α (ERα) expression in cartilage is important for the ameliorating effects of estrogen on synovitis, but not joint destruction.
36. Elevated levels of Wnt3a and low levels of Dickkopf-1 in serum are associated with syndesmophyte formation in ankylosing spondylitis
37. Modulation of IL-17 producing cells in estrogen-mediated inhibition of experimental arthritis
38. Hormone replacement therapy in postmenopausal women with rheumatoid arthritis stabilises bone mineral density by digital x-ray radiogrammetry in a randomised controlled trial
39. Elevated serum level of hepatocyte growth factor predicts development of new syndesmophytes in men with ankylosing spondylitis
40. Amelioration of collagen-induced arthritis and immune-associated bone loss through signaling via estrogen receptor α, and not estrogen receptor β or G protein–coupled receptor 30
41. The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial
42. Low Serum Levels of Sex Steroids Are Associated with Disease Characteristics in Primary Sjogren’s Syndrome; Supplementation with Dehydroepiandrosterone Restores the Concentrations
43. Additional file 1: of Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study
44. MOESM1 of A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin
45. Role of Raloxifene As A Potent inhibitor of Experimental Postmenopausal Polyarthritis and Osteoporosis
46. Immune responses and bone loss: the estrogen connection
47. Hepatocyte growth factor is a predictor of development of new syndesmophytes in men with ankylosing spondylitis. A five year prospective study
48. Weight loss improves disease activity in patients with psoriatic arthritis and obesity : an interventional study
49. The impact of a new immunomodulator oxo-quinoline-3-carboxamide on the progression of experimental lupus
50. Mycophenolic acid inhibits inosine 5′-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.